Sharon Wu

982 total citations
68 papers, 604 citations indexed

About

Sharon Wu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sharon Wu has authored 68 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 19 papers in Molecular Biology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sharon Wu's work include Endometrial and Cervical Cancer Treatments (9 papers), Cancer Genomics and Diagnostics (7 papers) and Acute Myeloid Leukemia Research (7 papers). Sharon Wu is often cited by papers focused on Endometrial and Cervical Cancer Treatments (9 papers), Cancer Genomics and Diagnostics (7 papers) and Acute Myeloid Leukemia Research (7 papers). Sharon Wu collaborates with scholars based in United States, Italy and Germany. Sharon Wu's co-authors include Houda Alachkar, Yang Du, David K. Ann, Mojtaba Akhtari, Curtis T. Okamoto, Michael B. Bolger, Sarah F. Hamm‐Alvarez, Ian S. Haworth, Hermann von Grafenstein and Sujit K. Basu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Sharon Wu

55 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon Wu United States 13 274 247 113 77 61 68 604
Eduard H. Panosyan United States 14 418 1.5× 175 0.7× 189 1.7× 36 0.5× 55 0.9× 31 1.0k
Linda Hogarth United Kingdom 14 387 1.4× 152 0.6× 82 0.7× 36 0.5× 33 0.5× 29 666
Alasdair C. Stamps United Kingdom 12 694 2.5× 291 1.2× 130 1.2× 54 0.7× 63 1.0× 16 1.0k
Rachel A. Egler United States 14 397 1.4× 152 0.6× 101 0.9× 22 0.3× 72 1.2× 25 907
Nicholas Davies United Kingdom 15 584 2.1× 298 1.2× 117 1.0× 20 0.3× 68 1.1× 25 1000
James E. Gervasoni United States 10 393 1.4× 352 1.4× 70 0.6× 43 0.6× 70 1.1× 15 725
Alok R. Singh United States 16 494 1.8× 216 0.9× 177 1.6× 25 0.3× 74 1.2× 25 858
Yoko Okitsu Japan 15 320 1.2× 198 0.8× 66 0.6× 27 0.4× 30 0.5× 49 647
Eva Groß Germany 18 547 2.0× 445 1.8× 154 1.4× 31 0.4× 90 1.5× 34 968
Kimie Kondo United States 15 484 1.8× 259 1.0× 127 1.1× 18 0.2× 65 1.1× 22 793

Countries citing papers authored by Sharon Wu

Since Specialization
Citations

This map shows the geographic impact of Sharon Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Wu more than expected).

Fields of papers citing papers by Sharon Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Wu. The network helps show where Sharon Wu may publish in the future.

Co-authorship network of co-authors of Sharon Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Wu. A scholar is included among the top collaborators of Sharon Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Wu. Sharon Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alvero, Ayesha B., Sharon Wu, Alex Farrell, et al.. (2025). Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis. Gynecologic Oncology. 194. 71–79. 2 indexed citations
2.
Qiu, Yuan-ye, et al.. (2025). Dystrophin interacts with Msp300 to regulate myonuclear positioning and microtubule organization. Journal of Cell Science. 138(17).
3.
Wu, Sharon, Sachin Kumar Deshmukh, Joanne Xiu, et al.. (2024). Genomic and tumor microenvironment dynamics of brain metastases in breast cancer.. Journal of Clinical Oncology. 42(16_suppl). 1018–1018.
4.
Malla, Midhun, Sachin Kumar Deshmukh, Sharon Wu, et al.. (2024). Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer. Cancer Gene Therapy. 31(10). 1547–1558. 6 indexed citations
5.
Gaillard, Stéphanie, Sachin Kumar Deshmukh, Utthara Nayar, et al.. (2024). Characterization of ESR1 mutations in endometrial and ovarian cancers.. Journal of Clinical Oncology. 42(16_suppl). 5598–5598. 1 indexed citations
6.
McNally, Leah, Sharon Wu, John Wallbillich, et al.. (2024). Molecular profiling of gestational trophoblastic neoplasia: Identifying therapeutic targets. Gynecologic Oncology. 184. 111–116. 5 indexed citations
7.
Wu, Sharon, Alex Farrell, Ling Gao, et al.. (2023). 559 Molecular characterization of Merkel cell carcinoma and association with Merkel cell polyomavirus. SHILAP Revista de lepidopterología. A639–A639.
8.
Nazha, Bassel, Sharon Wu, Jacqueline T. Brown, et al.. (2023). Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers. Cancer. 129(24). 3884–3893. 21 indexed citations
9.
Wu, Sharon, et al.. (2023). Assessment of the roles of Spt5-nucleic acid contacts in promoter proximal pausing of RNA polymerase II. Journal of Biological Chemistry. 299(9). 105106–105106. 6 indexed citations
10.
Cavalcante, Ludimila, Sachin Kumar Deshmukh, Jennifer R. Ribeiro, et al.. (2023). Opposing Roles of SPOP Mutations in Human Prostate and Endometrial Cancers. JCO Precision Oncology. 7(7). e2300088–e2300088. 4 indexed citations
11.
Deshmukh, Sachin Kumar, Sharon Wu, Joanne Xiu, et al.. (2023). Characterizing the role of PIM kinases in the prostate tumor immune microenvironment.. Journal of Clinical Oncology. 41(16_suppl). e17080–e17080. 1 indexed citations
12.
Deshmukh, Sachin Kumar, Felipe Batalini, Binbin Zheng-Lin, et al.. (2023). Chemotherapeutic sensitivity in colorectal cancer expressing low RNA of wild type homologous recombination genes.. Journal of Clinical Oncology. 41(16_suppl). 3531–3531. 1 indexed citations
13.
Hsu, Jeff, Jeffrey Serrill, Sharon Wu, et al.. (2022). Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER. Molecular Cancer Therapeutics. 22(2). 179–191. 12 indexed citations
14.
15.
Zhang, Tian Yi, et al.. (2020). Apolipoprotein C2 - CD36 Promotes Leukemia Growth and Presents a Targetable Axis in Acute Myeloid Leukemia. Blood Cancer Discovery. 1(2). 198–213. 27 indexed citations
16.
Wu, Sharon, et al.. (2018). Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia. Journal of Translational Medicine. 16(1). 170–170. 101 indexed citations
17.
Wu, Sharon, Mojtaba Akhtari, & Houda Alachkar. (2018). Characterization of Mutations in the Mitochondrial Encoded Electron Transport Chain Complexes in Acute Myeloid Leukemia. Scientific Reports. 8(1). 13301–13301. 31 indexed citations
18.
Wu, Sharon, et al.. (2017). Interaction between FLT3 and CD99 in Acute Myeloid Leukemia. Blood. 130. 3786–3786.
19.
Lee, Vincent H.L., Chun Chu, David K. Ann, et al.. (1999). Biopharmaceutics of transmucosal peptide and protein drug administration: role of transport mechanisms with a focus on the involvement of PepT1. Journal of Controlled Release. 62(1-2). 129–140. 26 indexed citations
20.
Ren, Shijun, Sharon Wu, & Eric J. Lien. (1998). Dihydroorotate Dehydrogenase Inhibitors: Quantitative Structure-activity Relationship Analysis. Pharmaceutical Research. 15(2). 286–295. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduard H. Panosyan Breakdown of academic impact, for papers by Linda Hogarth Breakdown of academic impact, for papers by Alasdair C. Stamps Breakdown of academic impact, for papers by Rachel A. Egler Breakdown of academic impact, for papers by Nicholas Davies Breakdown of academic impact, for papers by James E. Gervasoni Breakdown of academic impact, for papers by Alok R. Singh Breakdown of academic impact, for papers by Yoko Okitsu Breakdown of academic impact, for papers by Eva Groß Breakdown of academic impact, for papers by Kimie Kondo
Rankless by CCL
2026